“ovid-therapeutics” Archives

in
Entry Author Date Location
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug 09/30/20 New York
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M 04/01/19 New York
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
ICER, CRISPR, Biotech Activism & More: The X of the Year Finalists 08/15/18 Boston
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Don’t Be Boston 2.0, And Photos From “Bringing Back the Expats” 06/27/18 New York
Win Free Tickets to New York Biotech: Bringing Back the Expats! 05/31/18 National
Check Out the Agenda for New York Biotech: Bringing Back the Expats 05/23/18 National
Super Saver Rate Ending—NY Biotech: Bringing Back the Expats on 6/21 04/11/18 National
Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs 01/11/18 National
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Levin, Holtzman, 183 Other Bio Leaders Urge White House to Preserve DACA 09/07/17 National
Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers 08/24/17 Boston
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
Riding Recent Biotech IPO Wave, G1 Snags $105M to Fund Cancer Work 05/17/17 Raleigh Durham
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
On Tap For “What’s Hot” on May 11: Opioid Crisis, Immigration & More 04/13/17 Boston
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
NeuroPointDX, JCI, Resnick, & More: This Week’s Wisconsin Watchlist 02/13/17 Wisconsin
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Hunting For Pharma Deals, Ovid Bags Epilepsy Drug from Takeda 01/18/17 New York
Creating Bio “Gestalt” And Photos From New York Life Sciences 2021 12/19/16 New York
Hurry and Save 20 Percent on NY Life Sciences 2021 12/08/16 New York
Page 1 of 2 next page »